Thierry Andre
MD
Professor of Medical Oncology
👥Biography 个人简介
Thierry Andre led the landmark KEYNOTE-177 trial establishing pembrolizumab as first-line therapy for MSI-H/dMMR metastatic colorectal cancer. His decades of work on adjuvant chemotherapy and immunotherapy in CRC have defined treatment standards globally. He continues to advance novel immunotherapy combinations and predictive biomarker strategies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Thierry Andre 的研究动态
Follow Thierry Andre's research updates
留下邮箱，当我们发布与 Thierry Andre（Sorbonne University / Saint-Antoine Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment